• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Exopharm

Exopharm

  • Home
  • Products
  • Partnering
  • Science
  • Resources
    • ASX Announcements
    • Investor Information
    • News & Articles
    • Careers
  • About Us
    • Our Values
    • Our Team
    • Board of Directors
    • Scientific Advisory Board
  • Contact

Dr. Ian Dixon

  • All
  • EVs 101
  • News
  • Opinion Articles
  • Papers
  • Talks & Webinars
  • The Life of Science
  • Whitepapers

January 28, 2021 By Dr. Ian Dixon

Value in new medicines and ‘longer strides’

“There are more than 150 listed biotech companies on the ASX, so you need to back a select shortlist to outperform. While the science is often complex, look for companies that are capable of taking longer strides over the medium term,” says Dr. Ian Dixon, Managing Director & Founder. You can access the full Stockhead article […]

Filed Under: News, Opinion Articles

May 25, 2020 By Dr. Ian Dixon

Exosomes as Next-Generation Cell-free Medicines

Dr. Ian Dixon: Bio Insights Exosomes at scale as next-generation cell free medicines: Fact and Fiction In 2020, exosomes (also known as extracellular vesicles [EVs]) are emerging from academic laboratories and into biotechnology company led clinical trials. But this progress has, until now, been held back by the absence of a robust, scalable and proprietary […]

Filed Under: EVs 101, Opinion Articles, Whitepapers

April 13, 2020 By Dr. Ian Dixon

Seeing Exosomes’ Potential To Treat Sensory Disability

  Early studies suggest regenerative medicine could halt or even reverse the onset of age-related sensory impairment Gradually losing the ability to experience and enjoy the world around you can be one of the most debilitating aspects of ageing. Vision impairment, hearing loss and other sensory disabilities affecting smell, taste or touch are among the […]

Filed Under: EVs 101, Opinion Articles

January 31, 2020 By Dr. Ian Dixon

Exosomes: Nanoparticles full of Surprises

Exosomes: Nanoparticles full of Surprises If the past few years of exosome research has taught us anything about these tiny biomolecule-filled parcels, it is that ‘what do exosomes do?’ is the wrong question to ask. In the context of cell to cell communication, ‘what don’t exosomes do’ seems to be a better starting point. As […]

Filed Under: EVs 101, Opinion Articles

January 7, 2020 By Dr. Ian Dixon

Destination: Exosomes

Destination: Exosomes A growing number of stem cell companies are seeing the light and shifting their focus to exosome products. An interesting mixture of companies are lining up to follow Exopharm’s lead and begin human clinical trials of therapeutic exosome candidates. At least three exosome companies are aiming to start clinical trials during 2020, and […]

Filed Under: Opinion Articles

Exosomes as Drug Delivery Vehicles

December 17, 2019 By Dr. Ian Dixon

Exopharm backs regulatory crackdown on unapproved exosome products

Exopharm backs regulatory crackdown on unapproved exosome products A leading developer of exosome therapies, Australia-based Exopharm Limited, supports the US Food & Drug Administration (FDA) in highlighting the health dangers of unapproved products peddled by clinics that are openly flouting the rules. In a public safety notification released on December 6, the FDA highlighted reports […]

Filed Under: News

December 9, 2019 By Dr. Ian Dixon

What Are Exosomes and Why Are Exosomes Important?

What Are Exosomes and Why Are Exosomes Important? What Are Exosomes? Definition of Exosomes Exosomes are defined as nanometre-sized vesicles, being packages of biomolecules ranging from 40-150 nanometres in size that are released by virtually every cell type in the body. Once thought to be a kind of refuse disposal system for cells, exosomes are […]

Filed Under: EVs 101, Opinion Articles

December 5, 2019 By Dr. Ian Dixon

The New Science of Aging: Winding Back the Body Clock

The New Science of Aging: Winding Back the Body Clock Human age reversal has jumped from pure science fiction to research reality. Until very recently, the idea of age reversal and rejuvenation in humans was not a topic discussed in serious scientific circles. The idea was, at best, highly speculative. At worst it was the […]

Filed Under: Opinion Articles

Ageing and exosomes in regenerative medicine

October 30, 2019 By Dr. Ian Dixon

Turning Back the Body Clock With Exosomes

Turning Back the Body Clock With Exosomes New research reinforces the possibility that exosomes derived from stem cells can bring the body back into a more healthful, youthful state. Two recent publications highlight the growing relevance of exosomes to aging. One report highlights that the aging of humans is associated with an accelerating decline in […]

Filed Under: EVs 101, Opinion Articles

October 10, 2019 By Dr. Ian Dixon

Exosomes: Tiny Particles with Big Potential

The Potential of Exosomes Exosomes are moving toward clinical use in numerous and diverse ways There are around 37 trillion cells in a human body—and like any collective of diverse individuals they rely upon constant communication to work together. Just over a decade ago a research team in Sweden published in Nature Cell Biology a […]

Filed Under: EVs 101

regenerative medicine and exosome research

September 17, 2019 By Dr. Ian Dixon

The Power of Exosome Therapy in Regenerative Medicine

Understanding regenerative medicine’s point-of-difference Companies testing exosome-based therapies are developing completely new ways to tackle the wide array of medical conditions that afflict us in old age. Exosomes from stem cells are an emerging regenerative medicine that could disrupt the way age-related degeneration is treated, including problems such as cardiovascular disease, neurodegeneration, osteoporosis and erectile […]

Filed Under: EVs 101, Opinion Articles

Exosomes Therapeutics

August 6, 2019 By Dr. Ian Dixon

Exosomes and Therapeutic Research

Exosome Therapeutic Research Emerging from the Lab The more we study these naturally produced packets of biomolecules, the more therapeutic use they seem to lend themselves to be. Exosomes, pro-healing nanoparticles found naturally in the body, are a new potential paradigm in healthcare that could assist in every step we take through life. In their […]

Filed Under: EVs 101

Exosomes vs Stem Cell Therapys

July 17, 2019 By Dr. Ian Dixon

The Next Big Thing: Exosomes versus Stem Cells

Exosomes vs Stem Cells: Exosomes as the Next Big Thing after Stem Cell Therapy The exosomes (or ‘extracellular vesicles’) released by stem cells may be the disruptive therapy for tackling age-related diseases doctors and patients have been waiting for. Despite over a decade and a half of hope and hype, stem cell therapy has failed […]

Filed Under: News

Exopharm Reducing Risk - Making Drugs by Purifying not Synthesising

July 4, 2019 By Dr. Ian Dixon

Exopharm: Reducing Risk. Making Drugs by Purifying not Synthesising

Exopharm: Reducing Risk. Making Drugs by Purifying not Synthesising In this note to shareholders and potential investors, the company outlines Exopharm’s risk-profile and how the business of Exopharm compares with other types of listed biotechnology companies. Exopharm: Context Exopharm is an ASX listed regenerative medicine company focused on bringing exosomes into clinical use as a […]

Filed Under: News

What are Exosomes

June 11, 2019 By Dr. Ian Dixon

What are Exosomes and How Exosomes Work as a Regenerative Medicine

Exosomes (or extra cellular vesicles) are a new way to treat medical conditions including health span related medical problems. Exosomes are showing a great deal of promise in the Biotech industry as the future of regenerative medicine. What Are Exosomes? Exosomes are tiny packages of biomolecules released by cells1. They range between 40 and 200 […]

Filed Under: News

Anticipation in the Exosome Field

May 27, 2019 By Dr. Ian Dixon

Investors Show Growing Enthusiasm in Exosome Biotech Stocks

Biotech and Exosome Investment Growth Recent financial transactions highlight increasing biotech investment activity in the field of exosomes and extracellular vesicles. These naturally occurring packets of biomolecules could represent a new paradigm in healthcare. Exopharm Limited (ASX-EX1) is one of a small number of Australian biotech stocks currently attracting investors in regenerative medicine, and its […]

Filed Under: News

The power of Exopharm’s LEAP technology

March 27, 2019 By Dr. Ian Dixon

The Power of Exopharm’s LEAP Technology

The Critical Bottleneck of Exosome Isolation and the Power of Exopharm’s LEAP Technology Why Exopharm is poised to be a leader in the field of therapeutic exosomes. Exosomes (also known as extracellular vesicles or EVs) from stem cells are poised to become a new form of regenerative medicine – described by some as the ‘secret […]

Filed Under: News

What is Regenerative Medicine

January 31, 2019 By Dr. Ian Dixon

Australian Regenerative Medicine: Questions and Answers

Regenerative Medicine: Questions and Answers What is regenerative medicine? Regenerative medicine is a term used to cover different ways scientists can harness the body’s own regenerative capabilities. What are some examples of regenerative medicines? An old example is blood. Blood (or blood plasma) from donors is used routinely in hospitals if the patient needs more […]

Filed Under: News

Exosome introduction Notes

January 1, 2018 By Dr. Ian Dixon

Meet the Exosomes

Meet the Exosomes Exactly a decade ago, a seminal paper revealed the role exosomes play in the body. Read on for Exopharm’s guide on what exosomes are, and why they’re beginning to create a buzz in medical circles. Human cells are a gregarious bunch – otherwise we would fall apart. They continually message each other, […]

Filed Under: News

Exosome research

July 1, 2017 By Dr. Ian Dixon

Clearing the Hurdles with Exosomes

Could exosome therapy help athletes recover from injury faster – and help the rest of us by mimicking the whole-body benefits of exercise? Some people don’t get enough physical exercise – but others suffer from too much activity, injury and over-training. Many sports players are set to benefit from the dawning era of exosome medicine. […]

Filed Under: News

Exosomes as Drug Delivery Vehicles

January 1, 2017 By Dr. Ian Dixon

Exosomes as Drug Delivery Vehicles

Exosomes as Drug Delivery Vehicles: Natural Nano-bio-drones In the not too distant future, click ‘buy’ on an internet shopping site and an autonomous drone will be dispatched to carry your new goods directly to your doorstop. For now, drone home-delivery is still science fiction – but inside the body, targeted autonomous delivery of packages is […]

Filed Under: News

Footer

Resources

  • ASX Announcements
  • Investor Information
  • Board of Directors
  • News & Articles

Information

  • Contact
  • Partnering
  • Join Our Mailing List
  • Privacy, Terms and Conditions
  • Facebook
  • LinkedIn
  • Twitter
  • Vimeo
Copyright © 2022 · Exopharm · ACN 163 765 991 · info@exopharm.com
Level 17/31 Queen St, Melbourne VIC Australia 3000 · P: +61 (0)3 9111 0026 ·

Web Design by Mallee Blue Media
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT